{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T00:13:06Z","timestamp":1794960786160,"version":"4.9.1"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T00:00:00Z","timestamp":1511308800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"JSPS KAKENHI","award":["15K09992"],"award-info":[{"award-number":["15K09992"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Systemic inflammation and poor nutritional status have a negative effect on the outcomes of cancer. Here, we analyzed the effects of the pretreatment inflammatory and nutritional status on clinical outcomes of locally advanced non-small-cell lung cancer (NSCLC) patients treated with chemoradiotherapy. We retrospectively reviewed 89 patients with locally advanced NSCLC treated with chemoradiotherapy between July 2006 and June 2013. Serum C-reactive protein (CRP) was assessed as an inflammatory marker, and serum albumin, body mass index (BMI) and skeletal mass index were assessed as nutritional status markers. The relationships between these markers and overall survival (OS) were assessed. The median OS was 24.6 months [95% confidence interval (CI): 19.4\u201339.3 months]. During follow-up, 58 patients (65%) had disease recurrence and 52 patients (58%) died. In multivariate Cox hazard analysis, CRP levels and BMI approached but did not achieve a significant association with OS (P = 0.062 and 0.094, respectively). Recursive partitioning analysis identified three prognostic groups based on hazard similarity (CRP-BMI scores): 0 = CRP &amp;lt; 0.3 mg\/dl, 1 = CRP \u2265 0.3 mg\/dl and BMI \u2265 18.5 kg\/m2, and 2 = CRP \u2265 0.3 mg\/dl and BMI &amp;lt; 18.5 kg\/m2. The CRP-BMI score was significantly associated with OS (P = 0.023). Patients with scores of 0, 1 and 2 had median OS of 39.3, 24.5 and 14.5 months, respectively, and the scores also predicted the probability of receiving salvage treatment after recurrence. The CRP-BMI score is thus a simple and useful prognostic marker of clinical outcome for patients with locally advanced NSCLC treated with chemoradiotherapy.<\/jats:p>","DOI":"10.1093\/jrr\/rrx060","type":"journal-article","created":{"date-parts":[[2017,10,5]],"date-time":"2017-10-05T07:08:45Z","timestamp":1507187325000},"page":"50-57","source":"Crossref","is-referenced-by-count":18,"title":["Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy"],"prefix":"10.1093","volume":"59","author":[{"given":"Takamasa","family":"Mitsuyoshi","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Matsuo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Itou","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Kyoto-Katsura Hospital, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Shintani","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Iizuka","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Hak","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mizowaki","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology and Image-applied Therapy, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,11,22]]},"reference":[{"key":"2020010903280006500_rrx060C1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/caac.21254","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"2020010903280006500_rrx060C2","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1016\/j.ejca.2012.12.023","article-title":"Radical treatment of non-small cell lung cancer during the last 5 years","volume":"49","author":"McCloskey","year":"2013","journal-title":"Eur J Cancer"},{"key":"2020010903280006500_rrx060C3","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/jnci\/djr325","article-title":"Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410","volume":"103","author":"Curran","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"2020010903280006500_rrx060C4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12885-015-1379-6","article-title":"A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein\/albumin ratio","volume":"15","author":"Wei","year":"2015","journal-title":"BMC Cancer"},{"key":"2020010903280006500_rrx060C5","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/bjc.2012.350","article-title":"Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery","volume":"107","author":"Lieffers","year":"2012","journal-title":"Br J Cancer"},{"key":"2020010903280006500_rrx060C6","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.ctrv.2012.08.003","article-title":"The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer","volume":"39","author":"McMillan","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"2020010903280006500_rrx060C7","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/bjs.9893","article-title":"Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies","volume":"102","author":"Levolger","year":"2015","journal-title":"Br J Surg"},{"key":"2020010903280006500_rrx060C8","first-page":"3001","article-title":"Preoperative serum C-reactive protein level in non-small cell lung cancer","volume":"27","author":"Hara","year":"2007","journal-title":"Anticancer Res"},{"key":"2020010903280006500_rrx060C9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ijrobp.2015.02.018","article-title":"Pretreatment Modified Glasgow Prognostic Score predicts clinical outcomes after stereotactic body radiation therapy for early-stage non-small cell lung cancer","volume":"92","author":"Kishi","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2020010903280006500_rrx060C10","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/JTO.0b013e318244ffe1","article-title":"Clinical utility of the Pretreatment Glasgow Prognostic Score in patients with advanced inoperable non-small cell lung cancer","volume":"7","author":"Leung","year":"2012","journal-title":"J Thorac Oncol"},{"key":"2020010903280006500_rrx060C11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.lungcan.2007.03.017","article-title":"Nutritional status affects long term survival after lobectomy for lung cancer","volume":"57","author":"Tewari","year":"2007","journal-title":"Lung Cancer"},{"key":"2020010903280006500_rrx060C12","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1007\/s00520-014-2534-3","article-title":"Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer","volume":"23","author":"Kimura","year":"2015","journal-title":"Support Care Cancer"},{"key":"2020010903280006500_rrx060C13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1471-2407-13-158","article-title":"Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review","volume":"13","author":"Jafri","year":"2013","journal-title":"BMC Cancer"},{"key":"2020010903280006500_rrx060C14","doi-asserted-by":"crossref","first-page":"e3582","DOI":"10.1097\/MD.0000000000003582","article-title":"Clinical implication of inflammation-based prognostic score in pancreatic cancer: Glasgow Prognostic Score is the most reliable parameter","volume":"95","author":"Yamada","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"2020010903280006500_rrx060C15","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000355148","article-title":"A comparison of systemic inflammation-based prognostic scores in patients on regular hemodialysis","volume":"3","author":"Kato","year":"2013","journal-title":"Nephron Extra"},{"key":"2020010903280006500_rrx060C16","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/sj.bjc.6601242","article-title":"Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer","volume":"89","author":"Forrest","year":"2003","journal-title":"Br J Cancer"},{"key":"2020010903280006500_rrx060C17","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s00520-015-2997-x","article-title":"Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer","volume":"24","author":"Go","year":"2016","journal-title":"Support Care Cancer"},{"key":"2020010903280006500_rrx060C18","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/cncr.28018","article-title":"Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study","volume":"119","author":"Proctor","year":"2013","journal-title":"Cancer"},{"key":"2020010903280006500_rrx060C19","first-page":"1","article-title":"Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee","volume":"854","author":"WHO Expert Committee on Physical Status.","year":"1995","journal-title":"World Health Organ Tech Rep Ser"},{"key":"2020010903280006500_rrx060C20","first-page":"351","article-title":"[Radiation pneumonitis after stereotactic body radiation therapy for early stage non-small cell lung cancer]","volume":"17","author":"Chen","year":"2014","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"2020010903280006500_rrx060C21","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"2020010903280006500_rrx060C22","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1152\/japplphysiol.00744.2004","article-title":"Total body skeletal muscle and adipose tissue volumes: estimation from a single abdominal cross-sectional image","volume":"97","author":"Shen","year":"2004","journal-title":"J Appl Physiol (1985)"},{"key":"2020010903280006500_rrx060C23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"2020010903280006500_rrx060C24","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1007\/s11605-012-1923-5","article-title":"Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma","volume":"16","author":"Peng","year":"2012","journal-title":"J Gastrointest Surg"},{"key":"2020010903280006500_rrx060C25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12885-015-1389-4","article-title":"Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors","volume":"15","author":"Pottgen","year":"2015","journal-title":"BMC Cancer"},{"key":"2020010903280006500_rrx060C26","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/sim.4780080503","article-title":"A comparison of estimated proportional hazards models and regression trees","volume":"8","author":"Segal","year":"1989","journal-title":"Stat Med"},{"key":"2020010903280006500_rrx060C27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2020010903280006500_rrx060C28","doi-asserted-by":"crossref","first-page":"e314S","DOI":"10.1378\/chest.12-2360","article-title":"Treatment of stage III non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Ramnath","year":"2013","journal-title":"Chest"},{"key":"2020010903280006500_rrx060C29","first-page":"155","article-title":"Radiological and \u2018imaging\u2019 methods in TNM classification of non-small-cell lung cancer","volume":"28","author":"Gjurchinov","year":"2007","journal-title":"Prilozi"},{"key":"2020010903280006500_rrx060C30","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1016\/j.ejca.2011.03.028","article-title":"A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study","volume":"47","author":"Proctor","year":"2011","journal-title":"Eur J Cancer"},{"key":"2020010903280006500_rrx060C31","doi-asserted-by":"crossref","first-page":"e106914","DOI":"10.1371\/journal.pone.0106914","article-title":"Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer","volume":"9","author":"Alifano","year":"2014","journal-title":"PLoS One"},{"key":"2020010903280006500_rrx060C32","first-page":"966","article-title":"C-reactive protein as a prognostic marker in patients with hepatocellular carcinoma","volume":"62","author":"Kinoshita","year":"2015","journal-title":"Hepatogastroenterology"},{"key":"2020010903280006500_rrx060C33","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1245\/s10434-012-2498-9","article-title":"C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer","volume":"19","author":"Platt","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"2020010903280006500_rrx060C34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0002-9610(01)00684-5","article-title":"Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma","volume":"182","author":"Nozoe","year":"2001","journal-title":"Am J Surg"},{"key":"2020010903280006500_rrx060C35","first-page":"10633","article-title":"Association between serum C-reactive protein value and prognosis of patients with non-small cell lung cancer: a meta-analysis","volume":"8","author":"Jing","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"2020010903280006500_rrx060C36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5603\/PiAP.2014.0055","article-title":"Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21\u20131) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer","volume":"82","author":"Szturmowicz","year":"2014","journal-title":"Pneumonol Alergol Pol"},{"key":"2020010903280006500_rrx060C37","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1111\/ajco.12091","article-title":"Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer","volume":"11","author":"Ni","year":"2015","journal-title":"Asia Pac J Clin Oncol"},{"key":"2020010903280006500_rrx060C38","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1007\/s00268-012-1766-y","article-title":"Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer","volume":"36","author":"Kawai","year":"2012","journal-title":"World J Surg"},{"key":"2020010903280006500_rrx060C39","first-page":"401","article-title":"Preoperative hypoalbuminemia is a risk factor for late bronchopleural fistula after pneumonectomy","volume":"16","author":"Matsuoka","year":"2010","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"2020010903280006500_rrx060C40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1017\/S002966511500419X","article-title":"Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later","volume":"75","author":"Ryan","year":"2016","journal-title":"Proc Nutr Soc"},{"key":"2020010903280006500_rrx060C41","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/JTO.0b013e31829cf942","article-title":"Body mass index and its association with clinical outcomes for advanced non-small-cell lung cancer patients enrolled on Eastern Cooperative Oncology Group clinical trials","volume":"8","author":"Dahlberg","year":"2013","journal-title":"J Thorac Oncol"},{"key":"2020010903280006500_rrx060C42","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1245\/s10434-015-4559-3","article-title":"Sarcopenia is a predictor of postoperative respiratory complications in patients with esophageal cancer","volume":"22","author":"Ida","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"2020010903280006500_rrx060C43","doi-asserted-by":"crossref","first-page":"e0115895","DOI":"10.1371\/journal.pone.0115895","article-title":"Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma","volume":"10","author":"Fukushima","year":"2015","journal-title":"PLoS One"},{"key":"2020010903280006500_rrx060C44","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-med-061509-131248","article-title":"Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies","volume":"62","author":"Dodson","year":"2011","journal-title":"Annu Rev Med"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jrr\/article-pdf\/59\/1\/50\/31607116\/rrx060.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jrr\/article-pdf\/59\/1\/50\/31607116\/rrx060.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,9]],"date-time":"2020-01-09T03:33:11Z","timestamp":1578540791000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/59\/1\/50\/4647146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,22]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,11,22]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rrx060","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,11,22]]}}}